urinary incontinence

Vivek Ramaswamy’s Urovant claims a big win in PhIII — but questions linger about a cheap generic and their branded rival
Vivek Ramaswamy’s Urovant claims a big win in PhIII — but questions linger about a cheap generic and their branded rival
Endpoints
Axovant
Alzheimer's disease
Roivant
Vivek Ramaswamy
Urovant
vibegron
urinary incontinence
Flag link:
Renovia Completes $42.3 Million Series B to Advance Pelvic Floor Treatment and Diagnostics
Renovia
urinary incontinence
devices
Flag link:
Medical College Of Wisconsin To Study New Incontinence Device
Medical College Of Wisconsin To Study New Incontinence Device
urinary incontinence
incontinence
InTone
Incontrol Medical
Flag link:
Botox: ‘A Pipeline in a Vial’
Botox: ‘A Pipeline in a Vial’
NY Times, NY
Botox
Allergan
migraines
urinary incontinence
Flag link:
Botox gets EU green light as bladder treatment
Botox gets EU green light as bladder treatment
Fierce Pharma
Botox
Europe
Allergan
urinary incontinence
Flag link:
GT Urological wraps up $4.6 million for urinary incontinence device
GT Urological wraps up $4.6 million for urinary incontinence device
GT Urological
urinary incontinence
ActiCuf Compression Pouch
Flag link:
Uroplasty Receives New Patent for Implantable Neuromodulation System and Method
Uroplasty Receives New Patent for Implantable Neuromodulation System and Method
Uroplasty
urinary incontinence
neuromodulation
Flag link:
FDA OKs American Medical's incontinence treatment
FDA OKs American Medical's incontinence treatment
MiniArc Precise
urinary incontinence
American Medical Systems
Flag link:
Astellas Pharma, Teva Reach Settlement Over Incontinence Medicine Vesicare
Astellas Pharma, Teva Reach Settlement Over Incontinence Medicine Vesicare
Bloomberg
Astellas
Teva Pharmaceuticals
settlements
Vesicare
urinary incontinence
Flag link:
Frustrated by FDA, Uromedica attempts to innovate clinical trial
Frustrated by FDA, Uromedica attempts to innovate clinical trial
FDA
Uromedica
clinical trials
urinary incontinence
Flag link: